COMMUNIQUÉS West-GlobeNewswire

Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
05/01/2026
SAN DIEGO, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) (“Crinetics”), a pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for [...]
Fifty1 Labs, Inc. Clarifies Status Regarding Previously Announced Collaboration with LUNR Aerospace
05/01/2026
VANCOUVER, British Columbia, Jan. 05, 2026 (GLOBE NEWSWIRE) -- via IBN -- Fifty1 Labs, Inc. (OTC: FITY ) today issues the following clarification regarding its press release dated August 26, 2025, which referenced a [...]
SAFE - DEMISSION DE RODOLPHE CADIO ET NOMINATION DE NICOLAS PAPILLON AU CONSEIL D'ADMINISTRATION
05/01/2026
DEMISSION DE RODOLPHE CADIO ET NOMINATION DE NICOLAS PAPILLON AU CONSEIL D'ADMINISTRATION Fleurieux-sur-l’Arbresle – France – 5 janvier 2026 – 18h - Safe (FR001400ZU25 – ALSAF), annonce la démission de Rodolphe Cadio de [...]
Plum Tree Launches 2026 with Expanded Access to Mental Health Care for Children and Adolescents
05/01/2026
ST. CHARLES, Ill., Jan. 05, 2026 (GLOBE NEWSWIRE) -- As families enter the new year, Plum Tree Psychology, a child and adolescent behavioral health practice serving Kane County and surrounding communities, is expanding [...]
Idorsia’s daridorexant in women during menopausal transition age with insomnia
05/01/2026
New analysis of a Phase 3 study of daridorexant shows that 50 mg improved both sleep and daytime functioning compared to placebo in women during menopausal transition age Brigham and Women’s Hospital to study the [...]
Zealand Pharma to present at the J.P. Morgan Healthcare Conference
05/01/2026
Press release – No. 1 / 2026 Zealand Pharma to present at the J.P. Morgan Healthcare Conference Copenhagen, Denmark, January 5, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. [...]
DentPrime Publishes Comprehensive Patient Guidance Framework for Individuals Considering Dental Treatment Abroad
05/01/2026
Photo: DentPrime via FL Comms. ANTALYA, Türkiye, Jan. 05, 2026 (GLOBE NEWSWIRE) -- DentPrime today announced the publication of a comprehensive patient guidance framework designed to support individuals who are [...]
A Better Life Therapy Joins the Lumina Therapy Alliance, Marking a Major Expansion of the Nation’s Gold Standard for Concierge, In-Person Mental Health Care
05/01/2026
Elizabeth Earnshaw’s nationally recognized Philadelphia practice brings elite clinical leadership, cultural influence, and high-touch care to Lumina’s growing employer-focused network NEW YORK, Jan. 05, 2026 (GLOBE [...]
Pure Radiance Medispa Introduces Seattle’s First FDA-Cleared, Needle-Free Hair Growth Laser With Zero Downtime
05/01/2026
Non-surgical hormone-safe solution now available for patients seeking stronger, fuller, natural hair growth. Seattle, WA, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Pure Radiance Medispa , one of Seattle’s leading destinations [...]
Natural Weight Loss Florida Launches Habit-Based Support Program for Clients Using Weight-Loss Medications
05/01/2026
Innovative Service Aims to Build Sustainable Habits Alongside Medication Use Boca Raton, FL, Jan. 05, 2026 (GLOBE NEWSWIRE) -- As weight-loss medications such as GLP-1 therapies become increasingly common, many [...]
Coherus Oncology Announces Publication in Molecular Cancer Therapeutics Highlighting the Strong Pharmacology of Investigational CCR8 Antibody Tagmokitug (CHS-114)
05/01/2026
-Coherus Oncology formally introduces non-proprietary name: tagmokitug- -Publication shows picomolar affinity for CCR8 with no off-target binding and proof-of- mechanism in preclinical and clinical studies- -Data show [...]
Cosmos Health Enters Manufacturing Agreement with Libytec for PathMuscle Medicine, with Five-Year Volumes Expected to Exceed 1.2 Million Units
05/01/2026
CHICAGO, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) ( NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced that its wholly owned [...]
Processa Pharmaceuticals Completes Enrollment of 20th Patient for Formal Interim Analysis in Phase 2 NGC-Cap Breast Cancer Study
05/01/2026
Interim safety and efficacy data to be reported in Q1 VERO BEACH, Fla., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage biopharmaceutical company developing Next [...]
Psyence BioMed Achieves Milestone in Natural Ibogaine HCl Production and Strengthens Balance Sheet With No Debt and $12m Cash
05/01/2026
NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet [...]
Mainz Biomed Provides Review of 2025 Highlights
05/01/2026
Initiation of eAArly DETECT 2 - U.S. Clinical Study to Evaluate Performance of Next Generation Test on Advanced Adenomas over Large Patient Population in Preparation for ReconAAsense U.S. FDA Pivotal Trial Results from [...]
Polyrizon Announces New Pre-Clinical Results: PL-14 Demonstrates Significant Allergen-Blocking Performance Compared to a Standard Comparator
05/01/2026
Raanana, Israel, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company developing intranasal protective solutions today [...]
Alpha Tau Submits First Pre-Market Approval Module to the FDA for Alpha DaRT® for the Treatment of Recurrent Cutaneous Squamous Cell Carcinoma (cSCC)
05/01/2026
- Initial module submission marks an important milestone in the pre-market approval process - - Flexible modular submission framework granted to Alpha Tau by the FDA allows for streamlined review and feedback from the [...]
YD Bio Limited Announces Major Milestones and Unveils Robust 2026 Clinical and Commercial Roadmap
05/01/2026
Taipei, Taiwan, Jan. 05, 2026 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic [...]
Earth Science Tech, Inc. (ETST) Engages Hayden IR, Expanding Investor Relations Efforts to Support its Investor Outreach and Communications
05/01/2026
MIAMI, FL, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company, today announced that it has engaged Hayden IR, a nationally recognized investor [...]

Pages